Imexpharm Corp
VN:IMP
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24 572.8953
97 000
|
Price Target |
|
We'll email you a reminder when the closing price reaches VND.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one IMP stock under the Base Case scenario is 27 964.22 VND. Compared to the current market price of 41 350 VND, Imexpharm Corp is Overvalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Imexpharm Corp
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for IMP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Imexpharm Corp
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Imexpharm Corp
Balance Sheet Decomposition
Imexpharm Corp
Current Assets | 1.5T |
Cash & Short-Term Investments | 270.4B |
Receivables | 371.5B |
Other Current Assets | 824.9B |
Non-Current Assets | 1.1T |
Long-Term Investments | 71.3B |
PP&E | 862.1B |
Intangibles | 74.8B |
Other Non-Current Assets | 106.8B |
Current Liabilities | 431.6B |
Accounts Payable | 111B |
Accrued Liabilities | 106.9B |
Short-Term Debt | 104.2B |
Other Current Liabilities | 109.5B |
Earnings Waterfall
Imexpharm Corp
Revenue
|
2.2T
VND
|
Cost of Revenue
|
-1.4T
VND
|
Gross Profit
|
795.2B
VND
|
Operating Expenses
|
-459.8B
VND
|
Operating Income
|
335.4B
VND
|
Other Expenses
|
-88.2B
VND
|
Net Income
|
247.2B
VND
|
Free Cash Flow Analysis
Imexpharm Corp
VND | |
Free Cash Flow | VND |
IMP Profitability Score
Profitability Due Diligence
Imexpharm Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Imexpharm Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
IMP Solvency Score
Solvency Due Diligence
Imexpharm Corp's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
Imexpharm Corp's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IMP Price Targets Summary
Imexpharm Corp
According to Wall Street analysts, the average 1-year price target for IMP is 42 308.36 VND with a low forecast of 33 972.73 VND and a high forecast of 48 300 VND.
Dividends
Current shareholder yield for IMP is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Contact
IPO
Employees
Officers
The intrinsic value of one IMP stock under the Base Case scenario is 27 964.22 VND.
Compared to the current market price of 41 350 VND, Imexpharm Corp is Overvalued by 32%.